MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis.
Pranabananda DuttaMarianna SarkissyanKimberly PaicoYanyuan WuJaydutt V VadgamaPublished in: Breast cancer research and treatment (2018)
Our study suggests that MCP-1 mediated pathways could be potential therapeutic targets for the treatment of TNBC, and could reduce cancer health disparities.